// App-Quantinova.ai

3097 : The Benefit of Allogeneic Hematopoietic Cell Transplantation in Older Patients with Acute Myeloid Leukemia Is Restricted to Those in First Complete Remission At the Time of Transplantation.

Researchers

Presenter

  • Hans A. Messner

Principal Investigators

  • Eshetu G Atenafu

  • Dennis Dong Hwan Kim

  • John Kuruvilla

  • Jeffrey H. Lipton

  • Jieun Uhm

  • David Loach

  • Vikas Gupta

Medical Centers

  • Department of Medical Oncology and Hematology, Princess Margaret Hospital, University of Toronto, Toronto, ON, Canada

  • Division of Medical Oncology and Hematology, Princess Margaret Hospital, University Health Network, Toronto, ON, Canada,

  • Princess Margaret Hospital, Toronto, ON, Canada

  • Department of Biostatistics, Princess Margaret Hospital, University Health Network, Toronto, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute myelocytic leukemia

Biomarkers

  • Hematocrit

Drug/Treatment

  • GP2

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved